הבדלים בין גרסאות בדף "קוד ATC code - ATC"
מתוך ויקירפואה
שורה 1,148: | שורה 1,148: | ||
|A10AB02 | |A10AB02 | ||
[[Insulin (beef)]] | [[Insulin (beef)]] | ||
− | ||A10AB03 Insulin (pork) | + | |- |
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |A10AB03 | ||
+ | |[[Insulin (pork)]] | ||
|- | |- | ||
| | | | ||
שורה 1,169: | שורה 1,175: | ||
| | | | ||
|A10AB06 | |A10AB06 | ||
− | Insulin glulisine | + | |[[Insulin glulisine]] |
− | |A10AB30 Combinations | + | |- |
− | |A10AC Insulins and analogues for injection, intermediate-acting | + | | |
+ | | | ||
+ | | | ||
+ | | | ||
+ | |A10AB30 | ||
+ | [[Combinations]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |A10AC | ||
+ | | | ||
+ | |[[Insulins and analogues for injection, intermediate-acting]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AC01 Insulin (human) | |A10AC01 Insulin (human) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AC02 Insulin (beef) | |A10AC02 Insulin (beef) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AC03 Insulin (pork) | |A10AC03 Insulin (pork) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AC04 Insulin lispro | |A10AC04 Insulin lispro | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AC30 Combinations | |A10AC30 Combinations | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AD Insulins and analogues for injection, intermediate-acting |combined with fast-acting | |A10AD Insulins and analogues for injection, intermediate-acting |combined with fast-acting | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AD01 Insulin (human) | |A10AD01 Insulin (human) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AD02 Insulin (beef) | |A10AD02 Insulin (beef) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AD03 Insulin (pork) | |A10AD03 Insulin (pork) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AD04 Insulin lispro | |A10AD04 Insulin lispro | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AD05 Insulin aspart | |A10AD05 Insulin aspart | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AD30 Combinations | |A10AD30 Combinations | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AE Insulins and analogues for injection, long-acting | |A10AE Insulins and analogues for injection, long-acting | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AE01 Insulin (human) | |A10AE01 Insulin (human) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AE02 Insulin (beef) | |A10AE02 Insulin (beef) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AE03 Insulin (pork) | |A10AE03 Insulin (pork) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AE04 Insulin glargine | |A10AE04 Insulin glargine | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AE05 Insulin detemir | |A10AE05 Insulin detemir | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AE30 Combinations | |A10AE30 Combinations | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AF Insulins and analogues for inhalation | |A10AF Insulins and analogues for inhalation | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10AF01 Insulin (human) | |A10AF01 Insulin (human) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10B Blood glucose lowering drugs, excluding insulins | |A10B Blood glucose lowering drugs, excluding insulins | ||
− | + | |- | |
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BA Biguanides | |A10BA Biguanides | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BA01 Phenformin | |A10BA01 Phenformin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BA02 Metformin | |A10BA02 Metformin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BA03 Buformin | |A10BA03 Buformin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB Sulfonamides, urea derivatives | |A10BB Sulfonamides, urea derivatives | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB01 Glibenclamide | |A10BB01 Glibenclamide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB02 Chlorpropamide | |A10BB02 Chlorpropamide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB03 Tolbutamide | |A10BB03 Tolbutamide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB04 Glibornuride | |A10BB04 Glibornuride | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB05 Tolazamide | |A10BB05 Tolazamide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB06 Carbutamide | |A10BB06 Carbutamide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB07 Glipizide | |A10BB07 Glipizide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB08 Gliquidone | |A10BB08 Gliquidone | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB09 Gliclazide | |A10BB09 Gliclazide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB10 Metahexamide | |A10BB10 Metahexamide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB11 Glisoxepide | |A10BB11 Glisoxepide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB12 Glimepiride | |A10BB12 Glimepiride | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BB31 Acetohexamide | |A10BB31 Acetohexamide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BC Sulfonamides (heterocyclic) | |A10BC Sulfonamides (heterocyclic) | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BC01 Glymidine | |A10BC01 Glymidine | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD Combinations of oral blood glucose lowering drugs | |A10BD Combinations of oral blood glucose lowering drugs | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD01 Phenformin and sulfonamides | |A10BD01 Phenformin and sulfonamides | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD02 Metformin and sulfonamides | |A10BD02 Metformin and sulfonamides | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD03 Metformin and rosiglitazone | |A10BD03 Metformin and rosiglitazone | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD04 Glimepiride and rosiglitazone | |A10BD04 Glimepiride and rosiglitazone | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD05 Metformin and pioglitazone | |A10BD05 Metformin and pioglitazone | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD06 Glimepiride and pioglitazone | |A10BD06 Glimepiride and pioglitazone | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD07 Metformin and sitagliptin | |A10BD07 Metformin and sitagliptin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD08 Metformin and vildagliptin | |A10BD08 Metformin and vildagliptin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD09 Pioglitazone and alogliptin | |A10BD09 Pioglitazone and alogliptin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD10 Metformin and saxagliptin | |A10BD10 Metformin and saxagliptin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD11 Metformin and linagliptin | |A10BD11 Metformin and linagliptin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD12 Pioglitazone and sitagliptin | |A10BD12 Pioglitazone and sitagliptin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BD13 Metformin and alogliptin | |A10BD13 Metformin and alogliptin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BF Alpha glucosidase inhibitors | |A10BF Alpha glucosidase inhibitors | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BF01 Acarbose | |A10BF01 Acarbose | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BF02 Miglitol | |A10BF02 Miglitol | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BF03 Voglibose | |A10BF03 Voglibose | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BG Thiazolidinediones | |A10BG Thiazolidinediones | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BG01 Troglitazone | |A10BG01 Troglitazone | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BG02 Rosiglitazone | |A10BG02 Rosiglitazone | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BG03 Pioglitazone | |A10BG03 Pioglitazone | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors | |A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BH01 Sitagliptin | |A10BH01 Sitagliptin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BH02 Vildagliptin | |A10BH02 Vildagliptin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BH03 Saxagliptin | |A10BH03 Saxagliptin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BH04 Alogliptin | |A10BH04 Alogliptin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BH05 Linagliptin | |A10BH05 Linagliptin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BH51 Sitagliptin and simvastatin | |A10BH51 Sitagliptin and simvastatin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BX Other blood glucose lowering drugs, excluding insulins | |A10BX Other blood glucose lowering drugs, excluding insulins | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BX01 Guar gum | |A10BX01 Guar gum | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BX02 Repaglinide | |A10BX02 Repaglinide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BX03 Nateglinide | |A10BX03 Nateglinide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BX04 Exenatide | |A10BX04 Exenatide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BX05 Pramlintide | |A10BX05 Pramlintide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BX06 Benfluorex | |A10BX06 Benfluorex | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BX07 Liraglutide | |A10BX07 Liraglutide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BX08 Mitiglinide | |A10BX08 Mitiglinide | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10BX09 Dapagliflozin | |A10BX09 Dapagliflozin | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10X Other drugs used in diabetes | |A10X Other drugs used in diabetes | ||
− | + | |- | |
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10XA Aldose reductase inhibitors | |A10XA Aldose reductase inhibitors | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|A10XA01 Tolrestat | |A10XA01 Tolrestat | ||
− | |||
|- | |- | ||
| | | |
גרסה מ־16:16, 24 באוגוסט 2013
מפתח קודי ATC
גישה מהירה A / B / C / D / G / H / J / L / M / N / P / R / S / V
- הטבלא ניתנת למיון לפי כל אחת מהעמודות